UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.905-911

2016

Volltextzugriff (PDF)

Hépatite Delta : épidémiologie, diagnostic, histoire naturelle et traitements

La revue de medecine interne, 2022-03, Vol.43 (3), p.160-169

2022

Volltextzugriff (PDF)

Delta hepatitis: Epidemiology, diagnostic, natural history and treatment

La revue de medecine interne, 2022-03, Vol.43 (3), p.160

2022

Volltextzugriff (PDF)

Delta hepatitis: Epidemiology, diagnostic, natural history and treatment

La revue de medecine interne, 2022-03, Vol.43 (3), p.160-169

2022

Volltextzugriff (PDF)

Synthèse

Encéphale, 2008-09, Vol.34 (4), p.S47-S48

Castelnau, C.

2008

Volltextzugriff (PDF)

Long-Term Risk of Hepatocellular Carcinoma during Follow-Up of Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase

Journal of hepatology, 2016, Vol.64 (2), p.S356-S356

2016

Volltextzugriff (PDF)

Baseline HBsAg and HBcrAg Titers Allow Peginterferon Based “Precision Medicine” in Hbeag-Negative Chronic Hepatitis B

Journal of hepatology, 2016, Vol.64 (2), p.S597-S597

2016

Volltextzugriff (PDF)

P0800 : Effectiveness and safety of combination new regimens based on Sofosbuvir (SOFO) with Ribavirin (RBV), Daclatasvir (DAC) or Simeprevir (SIM) in difficult patients to treat infected with chronic hepatitis C (CHC)

Journal of hepatology, 2015-04, Vol.62, p.S634-S634

2015

Volltextzugriff (PDF)

P0656 : Add on peginterferon to adefovir enhances HBsAg loss in inactive HBV carriers

Journal of hepatology, 2015-04, Vol.62, p.S566-S566

2015

Volltextzugriff (PDF)

P0860 : The impact of interferon-free regimens on employment rate during treatment in patients with chronic hepatitis C

Journal of hepatology, 2015-04, Vol.62, p.S662-S663

2015

Volltextzugriff (PDF)

Risk Factors and Characteristics of Hepatocellular Carcinoma Occuring in HCV Cirrhotic Patients after Sustained Virological Response

Journal of hepatology, 2016, Vol.64 (2), p.S320-S320

2016

Volltextzugriff (PDF)

Risks of Liver Complications after a Long-Term Follow-Up in Patients with Chronic Hepatitis C with Sustained Virologic Response

Journal of hepatology, 2016, Vol.64 (2), p.S610-S610

2016

Volltextzugriff (PDF)

P998 BENEFIT OF SORAFENIB ACCORDING TO UNDERLYING LIVER DISEASE ETIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Journal of hepatology, 2014-04, Vol.60 (1), p.S407-S407

2014

Volltextzugriff (PDF)

P0657 : Adding tenofovir to Pegylated Interferon enhances end of treatment HBsAg loss in HBeAg negative chronic hepatitis B patients

Journal of hepatology, 2015-04, Vol.62, p.S566-S567

2015

Volltextzugriff (PDF)

P0822 : Safety And efficacy of sofosbuvir containing regimens for hepatitis C: Community treatment of a real world population with advanced liver fibrosis

Journal of hepatology, 2015-04, Vol.62, p.S645-S645

2015

Volltextzugriff (PDF)

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

Journal of viral hepatitis, 2011-08, Vol.18 (8), p.580-586

2011

Volltextzugriff (PDF)

Traitement de l'hépatite B

La Revue de médecine interne (Paris), 2002, Vol.23, p.535s-536s

2002

Volltextzugriff (PDF)

Troubles dépressifs subliminaires: description et intérêts pour la prévention secondaire en psychiatrie

Encéphale, 1998-09, Vol.24 (5), p.405-414

1998

Volltextzugriff (PDF)

391 ABSENCE OF INFLUENCE OF METABOLIC FACTORS ON DIAGNOSTIC PERFORMANCE OF LIVER STIFFNESS MEASUREMENT IN CHRONIC HEPATITIS B AND C

Journal of hepatology, 2010, Vol.52, p.S160-S161

2010

Volltextzugriff (PDF)

390 DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IS SIMILAR IN HEPATITIS B AND HEPATITIS C PATIENTS

Journal of hepatology, 2010, Vol.52, p.S160-S160

2010

Volltextzugriff (PDF)

806 EVALUATION OF TOLERANCE AND OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY SORAFENIB (AFTER THE SHARP STUDY)

Journal of hepatology, 2009, Vol.50, p.S295-S295

2009

Volltextzugriff (PDF)

Influence of cirrhosis on lamotrigine pharmacokinetics

British journal of clinical pharmacology, 2001-05, Vol.51 (5), p.410-414

2001

Volltextzugriff (PDF)

781 INCIDENCE AND PREDICTORS OF HCC IN CHRONIC HEPATITIS C PATIENTS WITH CIRRHOSIS AND NON RESPONDING TO PEGINTERFERON AND RIBAVIRIN THERAPY

Journal of hepatology, 2009, Vol.50, p.S286-S286

2009

Volltextzugriff (PDF)

Histoire naturelle des dysthyroïdies survenant sous interféron dans le traitement des hépatites chroniques C

Annales d'endocrinologie, 1996-11, Vol.57 (5), p.419-427

1996

Volltextzugriff (PDF)

635 INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTS

Journal of hepatology, 2009, Vol.50, p.S233-S234

2009

Volltextzugriff (PDF)

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(256)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Französisch
(168)
Englisch
(164)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients

Hépatite Delta : épidémiologie, diagnostic, histoire naturelle et traitements

Delta hepatitis: Epidemiology, diagnostic, natural history and treatment

Delta hepatitis: Epidemiology, diagnostic, natural history and treatment

Synthèse

Long-Term Risk of Hepatocellular Carcinoma during Follow-Up of Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase

Baseline HBsAg and HBcrAg Titers Allow Peginterferon Based “Precision Medicine” in Hbeag-Negative Chronic Hepatitis B

P0800 : Effectiveness and safety of combination new regimens based on Sofosbuvir (SOFO) with Ribavirin (RBV), Daclatasvir (DAC) or Simeprevir (SIM) in difficult patients to treat infected with chronic hepatitis C (CHC)

P0656 : Add on peginterferon to adefovir enhances HBsAg loss in inactive HBV carriers

P0860 : The impact of interferon-free regimens on employment rate during treatment in patients with chronic hepatitis C

Risk Factors and Characteristics of Hepatocellular Carcinoma Occuring in HCV Cirrhotic Patients after Sustained Virological Response

Risks of Liver Complications after a Long-Term Follow-Up in Patients with Chronic Hepatitis C with Sustained Virologic Response

P998 BENEFIT OF SORAFENIB ACCORDING TO UNDERLYING LIVER DISEASE ETIOLOGY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

P0657 : Adding tenofovir to Pegylated Interferon enhances end of treatment HBsAg loss in HBeAg negative chronic hepatitis B patients

P0822 : Safety And efficacy of sofosbuvir containing regimens for hepatitis C: Community treatment of a real world population with advanced liver fibrosis

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

Traitement de l'hépatite B

Troubles dépressifs subliminaires: description et intérêts pour la prévention secondaire en psychiatrie

391 ABSENCE OF INFLUENCE OF METABOLIC FACTORS ON DIAGNOSTIC PERFORMANCE OF LIVER STIFFNESS MEASUREMENT IN CHRONIC HEPATITIS B AND C

390 DIAGNOSTIC PERFORMANCE OF TRANSIENT ELASTOGRAPHY IS SIMILAR IN HEPATITIS B AND HEPATITIS C PATIENTS

806 EVALUATION OF TOLERANCE AND OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY SORAFENIB (AFTER THE SHARP STUDY)

Influence of cirrhosis on lamotrigine pharmacokinetics

781 INCIDENCE AND PREDICTORS OF HCC IN CHRONIC HEPATITIS C PATIENTS WITH CIRRHOSIS AND NON RESPONDING TO PEGINTERFERON AND RIBAVIRIN THERAPY

Histoire naturelle des dysthyroïdies survenant sous interféron dans le traitement des hépatites chroniques C

635 INSULIN RESISTANCE AND GEOGRAPHICAL ORIGIN ARE MAJOR PREDICTORS OF LIVER FIBROSIS AND RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN IN GENOTYPE 4 CHRONIC HEPATITIS C PATIENTS

Suchergebnisse filtern